NCT00233818View on ClinicalTrials.gov

FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 29, 2000

Study Completion Date

June 30, 2005

Conditions
Coronary Artery Disease
Interventions
DEVICE

Sirolimus-coated Bx VELOCITY Stent

Trial Locations (1)

NL- 3015 GD

Erasmus Centrum Thoraxcentrum, Rotterdam

Sponsors

Lead Sponsor

Cordis Corporation
All Listed Sponsors
lead

Cordis Corporation

INDUSTRY